HomeCompareEDTXF vs EPRT

EDTXF vs EPRT: Dividend Comparison 2026

EDTXF yields 203.25% · EPRT yields 3.92%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 EDTXF wins by $131.02M in total portfolio value
10 years
EDTXF
EDTXF
● Live price
203.25%
Share price
$0.98
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$131.09M
Annual income
$66,614,308.55
Full EDTXF calculator →
EPRT
EPRT
● Live price
3.92%
Share price
$30.77
Annual div
$1.21
5Y div CAGR
29%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$63.4K
Annual income
$12,840.73
Full EPRT calculator →

Portfolio growth — EDTXF vs EPRT

📍 EDTXF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodEDTXFEPRT
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, EDTXF + EPRT cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
EDTXF pays
EPRT pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

EDTXF
Annual income on $10K today (after 15% tax)
$17,276.42/yr
After 10yr DRIP, annual income (after tax)
$56,622,162.27/yr
EPRT
Annual income on $10K today (after 15% tax)
$332.87/yr
After 10yr DRIP, annual income (after tax)
$10,914.62/yr
At 15% tax rate, EDTXF beats the other by $56,611,247.65/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of EDTXF + EPRT for your $10,000?

EDTXF: 50%EPRT: 50%
100% EPRT50/50100% EDTXF
Portfolio after 10yr
$65.57M
Annual income
$33,313,574.63/yr
Blended yield
50.80%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on EPRT right now

EDTXF
No analyst data
Altman Z
-75.3
Piotroski
2/9
EPRT
Analyst Ratings
1
Strong
17
Buy
3
Hold
1
Sell
Consensus: Buy
Price Target
$35.50
+15.4% upside vs current
Range: $33.00 — $37.00
Altman Z
1.8
Piotroski
5/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

EDTXF buys
0
EPRT buys
0
No recent congressional trades found for EDTXF or EPRT in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricEDTXFEPRT
Forward yield203.25%3.92%
Annual dividend / share$2.00$1.21
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%29%
Portfolio after 10y$131.09M$63.4K
Annual income after 10y$66,614,308.55$12,840.73
Total dividends collected$123.65M$37.9K
Payment frequencyquarterlyquarterly
SectorStockREIT

Year-by-year: EDTXF vs EPRT ($10,000, DRIP)

YearEDTXF PortfolioEDTXF Income/yrEPRT PortfolioEPRT Income/yrGap
1← crossover$31,025$20,325.20$11,205$505.18+$19.8KEDTXF
2$92,131$58,933.98$12,672$682.46+$79.5KEDTXF
3$262,139$163,558.41$14,490$930.48+$247.6KEDTXF
4$715,413$434,925.03$16,786$1,282.69+$698.6KEDTXF
5$1,874,812$1,109,319.79$19,753$1,791.56+$1.86MEDTXF
6$4,722,949$2,716,900.45$23,677$2,541.64+$4.70MEDTXF
7$11,450,101$6,396,545.74$29,008$3,672.99+$11.42MEDTXF
8$26,744,592$14,492,983.16$36,463$5,425.08+$26.71MEDTXF
9$60,254,103$31,637,389.98$47,238$8,221.57+$60.21MEDTXF
10$131,086,199$66,614,308.55$63,385$12,840.73+$131.02MEDTXF

EDTXF vs EPRT: Complete Analysis 2026

EDTXFStock

Spectral Medical Inc., together with its subsidiaries, focuses on the development and commercialization of products for the treatment of septic shock and renal disease in North America. The company markets Endotoxin Activity Assay, a rapid in vitro diagnostic test for the detection of components of gram negative bacterial cell wall; and Polymyxin B Hemoperfusion, a therapeutic hemoperfusion device that removes endotoxin from the bloodstream. It also develops and manufactures monoclonal and polyclonal antibodies, recombinant cardiac proteins, and calibrators for use in the research and development, as well as products that are manufactured by other diagnostic companies; and develops platform for renal replacement therapy. The company was formerly known as Spectral Diagnostics Inc. and changed its name to Spectral Medical Inc. in December 2014. Spectral Medical Inc. was incorporated in 1991 and is headquartered in Toronto, Canada.

Full EDTXF Calculator →

EPRTREIT

Essential Properties Realty Trust, Inc., a real estate company, acquires, owns, and manages single-tenant properties in the United States. The company leases its properties to middle-market companies, such as restaurants, car washes, automotive services, medical and dental services, convenience stores, equipment rental, entertainment, early childhood education, grocery, and health and fitness on a long-term basis. As of December 31, 2021, it had a portfolio of 1, 451 properties. The company qualifies as a real estate investment trust for federal income tax purposes. It generally would not be subject to federal corporate income taxes if it distributes at least 90% of its taxable income to its stockholders. The company was founded in 2016 and is headquartered in Princeton, New Jersey.

Full EPRT Calculator →
📬

Get this EDTXF vs EPRT comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

EDTXF vs SCHDEDTXF vs JEPIEDTXF vs OEDTXF vs KOEDTXF vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.